Literature DB >> 19727067

DSM-IV depression with atypical features: is it valid?

Jonathan W Stewart1, Patrick J McGrath, Frederic M Quitkin, Donald F Klein.   

Abstract

Atypical features were incorporated into the American Psychiatric Association's Diagnostic and Statistical Manual, Fourth Edition (DSM-IV, 1994) as an illness specifier for major depression and dysthymia. The validity of depression with atypical features was supported by differences relative to depression with melancholic features in syndromal symptoms, course of illness, biology, family history, and treatment response. This paper reviews post-DSM-IV literature relevant to the validity of depression with atypical features. Most studies support the pre-DSM-IV findings. Again, course of illness, biological, family, and treatment differences are shown between melancholia and depression with atypical features. Several biologic studies report nondepressed controls have mean values between depressed subjects having atypical features and other depressed patients. This suggests atypical depression is a distinct depressive group rather than a milder form of melancholia. In addition, some studies show distinctions between depressed subjects with atypical features and those having neither atypical nor melancholic features. As depression with atypical features separates not only from melancholia but also from other depressed groups and controls over a range of meaningful distinctions, we conclude it is a valid clinical syndrome, useful both heuristically and in driving treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19727067     DOI: 10.1038/npp.2009.99

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  6 in total

1.  Lack of elevations in glucocorticoids correlates with dysphoria-like behavior after repeated social defeat.

Authors:  Nicole Bowens; Willem Heydendael; Seema Bhatnagar; Lauren Jacobson
Journal:  Physiol Behav       Date:  2011-11-12

2.  Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.

Authors:  Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-14       Impact factor: 4.035

Review 3.  Stress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypes.

Authors:  Jason J Radley; Mohamed Kabbaj; Lauren Jacobson; Willem Heydendael; Rachel Yehuda; James P Herman
Journal:  Stress       Date:  2011-09       Impact factor: 3.493

Review 4.  Atypical depression: current perspectives.

Authors:  Dorota Łojko; Janusz K Rybakowski
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-20       Impact factor: 2.570

Review 5.  Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective.

Authors:  Yang Li; Tong Liu; Weifeng Luo
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

6.  Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions.

Authors:  Margalida Gili; Miquel Roca; Silvia Armengol; David Asensio; Javier Garcia-Campayo; Gordon Parker
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.